• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

OPINIONI - Opinions

Volume:

Biochimica Clinica 2014; 38(3) 227-233

Pubblicato on-line:

DOI:

Scarica in PDF:
Autenticazione richiesta

Proteina S100B ed enolasi neurone-specifica nella valutazione iniziale del trauma cranico lieve nell’adulto: pronte per il debutto nel mondo reale?

AUTORI

Gianfranco Cervellin1, Mario Benatti1, Andrea Carbucicchio1, Rosalia Aloe2, Giuseppe Lippi2
1Unità Operativa Pronto Soccorso e Medicina d’Urgenza e 2Unità Operativa Diagnostica Ematochimica, Azienda OspedalieroUniversitaria di Parma

ABSTRACT

Protein S100B and neuron-specific enolase (NSE) for the initial evaluation of mild head trauma in adults: ready for prime time?

Computerized tomography (CT) remains the best option for diagnosis of head trauma, although it carries several drawbacks. Among a large number of putative biomarkers proposed for initial evaluation of mild head trauma, protein S100B and NSE exhibit the best diagnostic performance. We performed a prospective study, where these biomarkers were assessed in 68 patients consecutively admitted to the Emergency Department (ED) with mild head trauma. The CT scan revealed brain lesions in 11 patients (16%). Concentrations of both biomarkers in serum were found to be more elevated in patients with positive CT than in those with negative scans. The area under the ROC curve (AUC) of protein S100B (0.89, 95% confidence interval: 0.81-0.97) was, however, significantly greater than that of NSE (0.77, 95% confidence interval: 0.64-0.90) (P=0.044). It was estimated that determination of protein S100B in all patients presenting to the ED with mild head trauma could safely save up to 50% CT execution, reducing the overall healthcare expenditure by ~1/3.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967